LBO — THE MEDICAL CENTER
IRR: 24.1% | MOIC: 2.94x
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
24.1%
IRR
2.94x
MOIC
$193.9M
Entry EV
$384.4M
Exit EV
$99.7M
Equity Invested
Sources & Uses
S&UTotal · $193.9M| Item | Amount | % | Distribution |
|---|---|---|---|
| Senior Debt | $75.3M | 38.8% | |
| Sub Debt | $18.8M | 9.7% | |
| Equity | $99.7M | 51.5% | |
| Enterprise Value | $188.2M | 97.1% | |
| Transaction Fees | $5.6M | 2.9% | |
| Total Uses | $193.9M | 100.0% |
Interpretation
INTAt 2.94x MOIC and 24.1% IRR over 5 years, this deal exceeds the typical 20% hurdle — strong candidate.
Key drivers: Check the EBITDA bridge to identify highest-probability levers, the debt schedule for leverage trajectory, or the challenge solver to see what breaks the deal.
Returns Waterfall
WFL| Component | Value |
|---|---|
| Exit Ebitda | $36.6M |
| Exit Ev | $384.4M |
| Net Debt At Exit | $90.9M |
| Equity At Exit | $293.5M |
| Equity Invested | $99.7M |
| Total Value Created | $193.8M |
| Value From Growth | $186.8M |
| Value From Multiple | $9.4M |
| Value From Deleveraging | $3.2M |